|
Volumn 25, Issue 10, 2007, Pages 1110-1111
|
Network pharmacology
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
BETA LACTAM ANTIBIOTIC;
DNA TOPOISOMERASE (ATP HYDROLYSING) A;
DOPAMINE RECEPTOR;
IMATINIB;
NEUROLEPTIC AGENT;
PROTEIN PARC;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
SEROTONIN RECEPTOR;
SUNITINIB;
ANTIBACTERIAL ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
CELL DEATH;
DISEASE CLASSIFICATION;
DRUG DESIGN;
DRUG INHIBITION;
DRUG MECHANISM;
DRUG SCREENING;
DRUG TARGETING;
GENE EXPRESSION PROFILING;
GENETIC ASSOCIATION;
GENETIC DISORDER;
HUMAN;
MEDICAL LITERATURE;
NONHUMAN;
ONCOLOGY;
PHARMACOLOGICAL SCIENCE;
PHENOTYPE;
POLYPHARMACY;
PRIORITY JOURNAL;
PROTEIN PROTEIN INTERACTION;
PSYCHIATRY;
SHORT SURVEY;
STATISTICAL SIGNIFICANCE;
STRUCTURE ACTIVITY RELATION;
COMPUTER SIMULATION;
GENE EXPRESSION REGULATION;
GENOMICS;
HUMANS;
METABOLIC NETWORKS AND PATHWAYS;
MODELS, BIOLOGICAL;
PHARMACOLOGY;
SYSTEMS BIOLOGY;
|
EID: 35148824614
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1007-1110 Document Type: Short Survey |
Times cited : (1111)
|
References (9)
|